Cargando…
Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population
OBJECTIVES: Metabolically healthy obese (MHO) phenotype describes an obese state with a favorable metabolic profile. However, the prognosis of this subpopulation remains controversial. We aimed to examine whether MHO phenotype is associated with progression of atherosclerotic activity, reflected as...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395191/ https://www.ncbi.nlm.nih.gov/pubmed/28419118 http://dx.doi.org/10.1371/journal.pone.0175762 |
_version_ | 1783229834679287808 |
---|---|
author | Kang, Yu Mi Jung, Chang Hee Cho, Yun Kyung Lee, Seung Eun Lee, Min Jung Hwang, Jenie Yoonoo Kim, Eun Hee Park, Joong-Yeol Lee, Woo Je Kim, Hong-Kyu |
author_facet | Kang, Yu Mi Jung, Chang Hee Cho, Yun Kyung Lee, Seung Eun Lee, Min Jung Hwang, Jenie Yoonoo Kim, Eun Hee Park, Joong-Yeol Lee, Woo Je Kim, Hong-Kyu |
author_sort | Kang, Yu Mi |
collection | PubMed |
description | OBJECTIVES: Metabolically healthy obese (MHO) phenotype describes an obese state with a favorable metabolic profile. However, the prognosis of this subpopulation remains controversial. We aimed to examine whether MHO phenotype is associated with progression of atherosclerotic activity, reflected as the changes in coronary artery calcification (CAC) over time. If so, we sought to determine the role of fatty liver disease (FLD), the hallmark of hepatic steatosis, in this progression. METHODS: We enrolled 1,240 asymptomatic subjects who underwent repeated CAC score measurement during routine health examinations. CAC score progression was defined as either incident CAC in a population free of CAC at baseline, or an increase by ≥2.5 units between the baseline and final square root of CAC scores in participants with detectable CAC at baseline. Subjects were stratified by body mass index (cut-off, 25.0 kg/m(2)) and metabolic health state using Adult Treatment Panel-III criteria. FLD was assessed via ultrasonography. RESULTS: Over 2.9 years of follow-up, 25.2% of total subjects exhibited CAC score progression. The MHO phenotype was not significantly associated with CAC score progression (multivariate adjusted-odds ratio [OR], 1.45; 95% confidence interval [CI], 0.93–2.25), as compared to the metabolically healthy non-obese (MHNO) phenotype. However, subgroup analysis indicated that the MHO/FLD phenotype was significantly associated with CAC score progression (multivariate adjusted-OR, 2.37; 95% CI, 1.34–4.16), as compared to the MHNO/no FLD phenotype, whereas the MHO/no FLD phenotype was not (multivariate adjusted OR, 1.25; 95% CI, 0.71–2.24). CONCLUSIONS: Obese individuals with FLD have an increased risk of atherosclerosis progression, despite their healthy metabolic profile. Preventive interventions targeting cardiometabolic risk factors should be considered in such individuals, regardless of the weight status. |
format | Online Article Text |
id | pubmed-5395191 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-53951912017-05-04 Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population Kang, Yu Mi Jung, Chang Hee Cho, Yun Kyung Lee, Seung Eun Lee, Min Jung Hwang, Jenie Yoonoo Kim, Eun Hee Park, Joong-Yeol Lee, Woo Je Kim, Hong-Kyu PLoS One Research Article OBJECTIVES: Metabolically healthy obese (MHO) phenotype describes an obese state with a favorable metabolic profile. However, the prognosis of this subpopulation remains controversial. We aimed to examine whether MHO phenotype is associated with progression of atherosclerotic activity, reflected as the changes in coronary artery calcification (CAC) over time. If so, we sought to determine the role of fatty liver disease (FLD), the hallmark of hepatic steatosis, in this progression. METHODS: We enrolled 1,240 asymptomatic subjects who underwent repeated CAC score measurement during routine health examinations. CAC score progression was defined as either incident CAC in a population free of CAC at baseline, or an increase by ≥2.5 units between the baseline and final square root of CAC scores in participants with detectable CAC at baseline. Subjects were stratified by body mass index (cut-off, 25.0 kg/m(2)) and metabolic health state using Adult Treatment Panel-III criteria. FLD was assessed via ultrasonography. RESULTS: Over 2.9 years of follow-up, 25.2% of total subjects exhibited CAC score progression. The MHO phenotype was not significantly associated with CAC score progression (multivariate adjusted-odds ratio [OR], 1.45; 95% confidence interval [CI], 0.93–2.25), as compared to the metabolically healthy non-obese (MHNO) phenotype. However, subgroup analysis indicated that the MHO/FLD phenotype was significantly associated with CAC score progression (multivariate adjusted-OR, 2.37; 95% CI, 1.34–4.16), as compared to the MHNO/no FLD phenotype, whereas the MHO/no FLD phenotype was not (multivariate adjusted OR, 1.25; 95% CI, 0.71–2.24). CONCLUSIONS: Obese individuals with FLD have an increased risk of atherosclerosis progression, despite their healthy metabolic profile. Preventive interventions targeting cardiometabolic risk factors should be considered in such individuals, regardless of the weight status. Public Library of Science 2017-04-18 /pmc/articles/PMC5395191/ /pubmed/28419118 http://dx.doi.org/10.1371/journal.pone.0175762 Text en © 2017 Kang et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Kang, Yu Mi Jung, Chang Hee Cho, Yun Kyung Lee, Seung Eun Lee, Min Jung Hwang, Jenie Yoonoo Kim, Eun Hee Park, Joong-Yeol Lee, Woo Je Kim, Hong-Kyu Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population |
title | Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population |
title_full | Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population |
title_fullStr | Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population |
title_full_unstemmed | Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population |
title_short | Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population |
title_sort | fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395191/ https://www.ncbi.nlm.nih.gov/pubmed/28419118 http://dx.doi.org/10.1371/journal.pone.0175762 |
work_keys_str_mv | AT kangyumi fattyliverdiseasedeterminestheprogressionofcoronaryarterycalcificationinametabolicallyhealthyobesepopulation AT jungchanghee fattyliverdiseasedeterminestheprogressionofcoronaryarterycalcificationinametabolicallyhealthyobesepopulation AT choyunkyung fattyliverdiseasedeterminestheprogressionofcoronaryarterycalcificationinametabolicallyhealthyobesepopulation AT leeseungeun fattyliverdiseasedeterminestheprogressionofcoronaryarterycalcificationinametabolicallyhealthyobesepopulation AT leeminjung fattyliverdiseasedeterminestheprogressionofcoronaryarterycalcificationinametabolicallyhealthyobesepopulation AT hwangjenieyoonoo fattyliverdiseasedeterminestheprogressionofcoronaryarterycalcificationinametabolicallyhealthyobesepopulation AT kimeunhee fattyliverdiseasedeterminestheprogressionofcoronaryarterycalcificationinametabolicallyhealthyobesepopulation AT parkjoongyeol fattyliverdiseasedeterminestheprogressionofcoronaryarterycalcificationinametabolicallyhealthyobesepopulation AT leewooje fattyliverdiseasedeterminestheprogressionofcoronaryarterycalcificationinametabolicallyhealthyobesepopulation AT kimhongkyu fattyliverdiseasedeterminestheprogressionofcoronaryarterycalcificationinametabolicallyhealthyobesepopulation |